Researchers isolate human monoclonal antibodies that may neutralize several norovirus variants

Can't see this email? View it online

	Antibodies
	The latest antibodies news from News Medical

Researchers isolate human monoclonal antibodies that may neutralize several norovirus variants

Researchers at Vanderbilt University Medical Center and the Baylor College of Medicine in Houston, Texas, have taken a big step toward developing targeted treatments and vaccines against a family of viruses that attacks the gastrointestinal tract.

			IgA deficiency results in substantial intestinal inflammation, study reveals While researchers have known for years that immunoglobulin A (IgA) is important for gut health, it has remained unclear exactly what role it plays in preventing infection and disease. But now, researchers from Japan have found that eliminating IgA disrupts the balance of the intestinal ecosystem, making it susceptible to disease.

			Researchers find a potentially game-changing blood clot treatment A potentially game-changing treatment for people with, or at risk of, blood clots has been found effective by an international team of researchers led by McMaster University's Jeffrey Weitz.

	Selective immunotoxins may help treat liver fibrosis Chronic alcohol abuse and hepatitis can injure the liver and lead to fibrosis, the buildup of collagen and scar tissue. As a potential approach to treating liver fibrosis, University of California San Diego School of Medicine researchers and their collaborators are looking for ways to stop liver cells from producing collagen.

	Rapid, more accurate test to detect antibodies against SARS-CoV-2 spike protein Japanese researchers have come up with a highly accurate, rapid test for identifying antibodies against the SARS-CoV-2 spike protein in human serum.

	Scientists analyze the sensitivity of SARS-CoV-2 Delta variant to monoclonal antibodies The Delta variant was detected for the first time in India in October 2020 and has since spread throughout the world.

	Antibody levels remain high nine months after SARS-CoV-2 infection, study shows Testing of an entire Italian town shows antibody levels remain high nine months after SARS-CoV-2 infection, whether symptomatic or asymptomatic.

Website: www.news-medical.net

Email: [email protected]net

Telephone: +44 (0)161 457 7150

AZoNetwork UK Ltd.
NEO, 4th Floor
9 Charlotte Street, Manchester
M1 4ET, UK

Why did you receive this email?
You recently requested related information from us and asked to be notified of additional information.

Not interested anymore?
Unsubscribe or
Update Your Newsletter Subscriptions